Viewpoint

DOI: 10.4244/EIJ-D-24-00205

Subclinical leaflet thrombosis: should we be concerned?

George Dangas1, MD, PhD; Benjamin Bay1,2, MD

Since the first transcatheter aortic valve implantation (TAVI) on 16 April 2002, by the late Alain Cribier, as a percutaneous treatment for aortic stenosis, multiple studies have demonstrated the efficacy and safety of this approach. Over the last decade, with a refinement in imaging techniques and broad use of TAVI bioprostheses, subclinical leaflet thrombosis (SLT), quantified via four-dimensional computed tomography angiography (4D-CTA) and the imaging correlates, hypoattenuated leaflet thickening (HALT) and reduced leaflet motion have been identified as early complications after TAVI. In the clinical reality of patients without an indication for oral anticoagulation, core lab rates of HALT at 30 days and 1 year have been described at 24.5% and 32.0%, respectively1. Additionally, HALT does fluctuate regardless of medical therapy: most of the patients who had it at 1 month were not the same as those who had it at 1 year.

The impact of SLT on cardiovascular outcomes and early degeneration of TAVI bioprostheses remains poorly understood, with conflicting results reported in the literature. Hence, as controversy surrounds the clinical relevance of SLT, we should be considering several...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 14
Jul 15, 2024
Volume 20 Number 14
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00013 May 5, 2025
Further insights on subclinical leaflet thrombosis following valve-in-valve TAVI
De Backer O and Khokhar A
free

10.4244/EIJV13I15A281 Feb 2, 2018
Subclinical leaflet thrombosis – a concern, but also an issue?
Søndergaard L
free

AORTIC VALVE INTERVENTIONS

10.4244/EIJV12SYA7 Sep 18, 2016
Leaflet motion abnormality after TAVI: genuine threat or much ado about nothing?
Chakravarty T et al
free

10.4244/EIJV10I2A44 Jun 20, 2014
Two cases of thrombotic stenosis in SAPIEN XT valves after transapical implantation
Leetmaa T et al
free

10.4244/EIJV8I1A4 May 15, 2012
Embolic protection devices during TAVI – the “proof of the pudding”
Van Mieghem NM and Serruys PW
free
Trending articles
309.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
72.85

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved